Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gulati

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|December 23, 1995
Haematology. Peripheral stem-cell transplantationL Kumar, S C Gulati
Oncology (Williston Park, N.Y.)|February 1, 1994
Are we obtaining the maximum benefit from GM-CSF and G-CSF?S C Gulati, S Duensing
Stem Cells (Dayton, Ohio)|March 1, 1994
Leukemia and bone marrow microenvironmentS C Gulati, B Nath
Cancer Investigation|January 1, 1993
Improving the role of hematopoietic support for high-dose cytotoxic therapyS C Gulati, L Acaba
Indian Journal of Pediatrics|November 1, 1983
NeuroblastomaS C Gulati, R Vega, L Gandola, et al.
Lancet (London, England)|March 30, 1996
High-dose chemotherapy with autologous bone marrow/stem-cell rescue in lung cancerM M Basade, S C Gulati
Stem Cells (Dayton, Ohio)|September 1, 1993
Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow culturesR M Lemoli, S C Gulati
Annals of Internal Medicine|February 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin diseaseS C Gulati, C L Bennett
Experimental Hematology|October 1, 1990
In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitorsR M Lemoli, S C Gulati
Leukemia & Lymphoma|July 31, 1998
p53 gene mutation in the bone-marrow of a patient with diffuse mixed cell type lymphoma at diagnosis predicting eventual progression to large cell lymphomaM Jhanwar-Uniyal, S C Gulati
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|December 23, 1995
Haematology. Peripheral stem-cell transplantationL Kumar, S C Gulati
Oncology (Williston Park, N.Y.)|February 1, 1994
Are we obtaining the maximum benefit from GM-CSF and G-CSF?S C Gulati, S Duensing
Stem Cells (Dayton, Ohio)|March 1, 1994
Leukemia and bone marrow microenvironmentS C Gulati, B Nath
Cancer Investigation|January 1, 1993
Improving the role of hematopoietic support for high-dose cytotoxic therapyS C Gulati, L Acaba
Indian Journal of Pediatrics|November 1, 1983
NeuroblastomaS C Gulati, R Vega, L Gandola, et al.
Lancet (London, England)|March 30, 1996
High-dose chemotherapy with autologous bone marrow/stem-cell rescue in lung cancerM M Basade, S C Gulati
Stem Cells (Dayton, Ohio)|September 1, 1993
Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow culturesR M Lemoli, S C Gulati
Annals of Internal Medicine|February 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin diseaseS C Gulati, C L Bennett
Experimental Hematology|October 1, 1990
In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitorsR M Lemoli, S C Gulati
Leukemia & Lymphoma|July 31, 1998
p53 gene mutation in the bone-marrow of a patient with diffuse mixed cell type lymphoma at diagnosis predicting eventual progression to large cell lymphomaM Jhanwar-Uniyal, S C Gulati
Pageof 12